East Lansing, MI · Founded 2018 · Privately Held (backing)
Operator of synthetic antigen-based vaccines designed to prevent and treat infectious diseases. Iaso Therapeutics is based in East Lansing, MI and was founded in 2018. Its last reported valuation was $5.3 million in Jan 2023. It has raised $1.8 million across 2 recorded rounds; the latest was a $570,000 seed round in Jan 2026.
Last reported valuation
$5.3M
Oct 2026
Priced at
—
Total raised
$1.8M
Last round
Seed Round
Jan 2026
No prints on record
No secondary trades in Iaso Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Iaso Therapeutics with a free account
·Watch Iaso Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Iaso Therapeutics stock.
